Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1V32
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,604
Award facts
- Contract value 100% obligated
- $55,604.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $55,604.01 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of Dupixent 300 mg/2 mL pens. This non-set-aside contract represents a single delivery order with an ultimate completion date of January 16, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), one of the nation's largest pharmaceutical distributors serving federal government healthcare systems.
This delivery order falls under Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 31, 2031), which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to military healthcare programs globally. The contract vehicle enables efficient fulfillment of essential medications across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Dupixent (dupilumab) is a specialty biologic medication used to treat moderate-to-severe eczema, asthma, and other inflammatory conditions, reflecting the company's portfolio of brand-name specialty pharmaceuticals procured through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F1V32?
SPE2DR26F1V32 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F1V32 worth?
The government has obligated $55,604 on SPE2DR26F1V32.
Is contract SPE2DR26F1V32 an order under another contract?
Yes. SPE2DR26F1V32 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1V32 competed?
The extent of competition for SPE2DR26F1V32 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award